Document:

<PAGE>

                                                                    EXHIBIT 10.5

                              AMENDED AND RESTATED

                         REGISTRATION RIGHTS AGREEMENT

                            SONIC INNOVATIONS, INC.

                                October 23, 1998
<PAGE>

                               TABLE OF CONTENTS

<TABLE>
<CAPTION>
                                                                            Page
                                                                            ----
<S>                                                                         <C>
 1.  Definitions...........................................................   1

 2.  Registration Rights...................................................   1

     2.1  Piggyback Registration...........................................   1
     2.2  Demand Registration..............................................   2
     2.3  Registration on Form S-3.........................................   2
     2.4  Registration Procedures..........................................   3
     2.5  Certain Conditions to Registration...............................   4
     2.6  Notices of Registration Statements, Etc..........................   5
     2.7  Indemnity........................................................   5

 3.  Expenses..............................................................   7

 4.  Reports Under the Exchange Act........................................   7

 5.  Transfer of Registration Rights.......................................   8

 6.  Termination of Registration Rights....................................   8

 7.  Future Registration Rights............................................   8

 8.  Modification and Waiver...............................................   8

 9.  Notices...............................................................   9

10.  Gender and Number, Etc................................................   9

11.  Successors and Assigns................................................   9

12.  Counterparts..........................................................   9

13.  Entire Agreement and Captions.........................................   9

14.  Governing Law.........................................................   9

15.  Severability..........................................................   9

16.  No Third Party Beneficiaries..........................................  10

17.  No Partnership or Joint Venture.......................................  10

18.  No Impairment.........................................................  10
</TABLE>

                                       i
<PAGE>

                              AMENDED AND RESTATED

                         REGISTRATION RIGHTS AGREEMENT

     THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (the "Agreement"),
dated as of October 23, 1998, is entered into by and among Sonic Innovations,
Inc., a Delaware corporation (the "Company"), and the holders of Series A
Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D
Preferred Stock set forth on Exhibit A.

     WHEREAS, the holders of Series A Preferred Stock, Series B Preferred Stock
and Series C Preferred Stock and the Company previously entered into an Amended
and Restated Registration Rights Agreement dated October 31, 1997, and desire
that this Agreement supersede and replace in its entirety such prior agreement;

     WHEREAS, contemporaneously with the execution of this Agreement, the
holders of Series D Preferred Stock are purchasing shares of Series D Preferred
Stock of the Company pursuant to a Series D Preferred Stock Purchase Agreement
dated as of the date hereof (the "Purchase Agreement"), and this Agreement is
executed as additional consideration for the holders of Series D Preferred Stock
to enter into the Purchase Agreement.

     NOW, THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties hereto agree as
follows:

     1.   Definitions

          (a) The holders of Series A Preferred Stock, the holders of Series B
Preferred Stock, the holders of Series C Preferred Stock and the holders of
Series D Preferred Stock and any assigns shall hereinafter be collectively
referred to as the "Stockholders."

          (b) "Shares" shall mean and include any of the following securities:
(i) the shares of common stock of the Company (the "Common Stock") held by the
Stockholders upon conversion of the Series A Preferred Stock, Series B Preferred
Stock, Series C Preferred Stock or Series D Preferred Stock, (ii) the Series A
Preferred Stock, (iii) the Series B Preferred Stock, (iv) the Series C Preferred
Stock, (v) the Series D Preferred Stock, or (vi) any additional securities
issued to the Stockholders with respect to the foregoing upon any stock split,
stock dividend, recapitalization, dilution, adjustment or similar event.

     2.   Registration Rights

          2.1  Piggyback Registration.  If at any time the Company shall propose
to file with the Securities and Exchange Commission (the "Commission") on behalf
of the Company or any other shareholder a registration statement under the
Securities Act of 1933, as amended (the "Securities Act"), with respect to any
class of security (as defined in Section 3(a)(10) of the Securities Exchange Act
of 1934, as amended (the "Exchange Act")), other than a registration

                                      -3-
<PAGE>

statement approved by the Board of Directors on Form S-4 or S-8, or such amended
or alternative form for Form S-4 or S-8 as the Commission may from time to time
adopt, the Company shall in each case timely notify the Stockholders and include
in such registration statement all of the Shares as the Stockholders may request
within twenty (20) days after the Company's giving of such notice, subject to
the conditions set forth herein.

          2.2  Demand Registration.  If at any time commencing the earlier of
three years from the date of this Agreement or six months after an initial
registration of the Company's Common Stock, the Company shall receive from the
Stockholders holding 30% or more of the Common Stock issued or issuable upon
conversion of the Series B Preferred Stock, Series C Preferred Stock and Series
D Preferred Stock (the "Initiating Stockholders"), a written request that the
Company effect a registration for aggregate proceeds in excess of $7,500,000
with respect to the Shares held by the Stockholders to permit the sale or
disposition thereof, the Company shall promptly, subject to the conditions and
in accordance with the procedures hereinafter set forth, file a registration
statement on an appropriate form as expeditiously as reasonably possible
covering such Shares; provided, however, that the Company shall not be obligated
to effect, or take any action to effect, any such registration pursuant to this
Section 2.2: (i) in any particular jurisdiction in which the Company would be
required to execute a general consent to service of process in effecting such
registration, qualification or compliance, unless the Company is already subject
to service in such jurisdiction and except as may be required by the Securities
Act or applicable rules or regulations thereunder or (ii) after the Company has
effected two (2) such registrations pursuant to Section 2.2 and such
registrations have been declared or ordered effective and the sales of such
Registrable Securities shall have closed.

          2.3  Registration on Form S-3.  After the initial public offering of
the Company's Common Stock pursuant to a registration statement filed with and
declared effective by the Commission under the Act (the "Initial Public
Registration"), the Company shall use its best efforts to qualify for
registration on Form S-3 or any comparable or successor form or forms. After the
Company has qualified for the use of Form S-3, in addition to the rights
contained in the foregoing provisions of this Section 2, upon initiation of
holders of 20% of the outstanding shares of the Company's Preferred Stock
("Preferred Stock"), the Stockholders shall have the right to request
registrations on Form S-3 (such requests shall be in writing and shall state the
number of Shares to be disposed of and the intended methods of disposition of
such Shares by such holder or holders); provided, however, that the Company
shall not be obligated to effect any such registration (i) if a Form S-3
registration is unavailable; (ii) if the Stockholders, together with the holders
of any other securities of the Company entitled to inclusion in such
registration, propose to sell Shares (if any) on Form S-3 at an aggregate price
to the public of less than $500,000; (iii) if there has been more than two
registrations by the Company on Form S-3 in the previous 12-month period; (iv)
in any particular jurisdiction in which the Company would be required to execute
a general consent to service of process in effecting such registration,
qualification or compliance, unless the Company is already subject to service in
such jurisdiction and except as may be required by the Securities Act or
applicable rules or regulations thereunder; or (v) if the Board of Directors of
the Company determines that such Form S-3 registration would be seriously
detrimental to the Company, in which case such registration may be delayed for a
period not to exceed 60 days.

                                      -2-
<PAGE>

          2.4  Registration Procedures.  If, pursuant to Sections 2.1, 2.2, or
2.3 hereof, the Company is required to include any Shares in a registration
statement proposed to be filed, the Company will, as expeditiously as possible:
(a) prepare and file such registration statement under the Securities Act on an
appropriate form and use its best efforts to cause such registration statement
to become effective; (b) prepare and file with the Commission such amendments
and supplements to such registration statement and the prospectus used in
connection therewith as may be necessary to comply with the provisions of the
Securities Act and the Exchange Act with respect to the offer of the securities
covered by such registration statement during the period required for
distribution of such securities; (c) furnish to the holder of such Shares such
number of copies of such registration statement and all amendments thereto and
of such prospectus (including each preliminary, amended or supplemental
prospectus) as such holders may reasonably request in order to facilitate the
sale or transfer of the securities covered by such registration statement; (d)
use its best efforts to register or qualify the securities covered by any such
registration statement in such jurisdictions as such holders may reasonably
request; provided, however, that the Company shall not be required in connection
therewith or as a condition thereto to qualify to do business or to file a
general consent to service of process in any such states or jurisdictions; (e)
enter into and perform its obligations under an underwriting agreement, in the
usual and customary form, with the managing underwriter of the offering; (f)
inform Stockholders of any event that renders the prospectus untrue or
misleading; (g) cause all securities registered in the offering to become listed
on each securities exchange on which similar securities issued by the Company
are then listed; (h) provide a transfer agent, registrar and CUSIP number for
all securities registered no later than the effective date of the offering; (i)
furnish, at the request of the Stockholders, on the date that such Shares are
delivered to the underwriters for sale pursuant to such registration or, if such
Shares are not being sold through underwriters, on the date such registration
statement becomes effective (A) an opinion, dated on such date, in a form
customary to such transactions, of the independent counsel representing the
Company for the purposes of such registration, addressed to the underwriters, if
any, and to the Stockholders making such request, reasonably acceptable in form
and substance to such underwriters, if any, and the Stockholders and (B) a
letter, dated on such date, from the independent certified public accountants of
the Company, addressed to the underwriters, if any, and the Stockholders,
stating that they are independent certified public accountants within the
meaning of the Securities Act and that in the opinion of such accountants, the
financial statements and other financial data of the Company included in the
registration statement or the prospectus, or any amendment or supplement thereto
(including, in each case, documents incorporated by reference thereto), comply
as to form in all material respects with the applicable accounting requirements
of the Securities Act; such opinion of counsel shall additionally cover such
other legal matters with respect to the registration statement and the Company
as the underwriters, if any, or the Stockholders may reasonably request; and
such letter from the independent certified public accountants shall additionally
cover such other financial matters (including information as to the period
ending not more than five (5) business days prior to the date of such letter)
with respect to the registration statement and the Company as the underwriters,
if any, or the Stockholders may reasonably request; and (j) use its best efforts
to cause such registration statement to become effective, and, upon the request
of the holders of a majority of the registrable securities registered
thereunder, keep such registration statement effective for a period of up to one
hundred twenty (120) days or until the distribution contemplated in the
registration statement has been completed; provided, however, that

                                      -3-
<PAGE>

(i) such 120-day period shall be extended for a period of time equal to the
period the Shareholder refrains from selling any securities included in such
registration at the request of an underwriter of Common Stock (or other
securities) of the Company; and (ii) in the case of any registration of
registrable securities on Form S-3 which are intended to be offered on a
continuous or delayed basis, such 120-day period shall be extended, if
necessary, to keep the registration statement effective until all such
registrable securities are sold; provided, however, that Rule 415, or any
successor rule under the Securities Act, permits an offering on a continuous or
delayed basis; and provided, further, that applicable rules under the Securities
Act governing the obligation to file a post-effective amendment permit, in lieu
of filing a post-effective amendment which (A) includes any prospectus required
by Section 10(a)(3) of the Securities Act or (B) reflects facts or events
representing a material or fundamental change in the information set forth in
the registration statement, the incorporation by reference of information
required to be included in (A) and (B) above to be contained in periodic reports
filed pursuant to Section 13 or 15(d) of the Exchange Act in the registration
statement.

          2.5  Certain Conditions to Registration.

               (a) The right of the Stockholders to have any Shares included in
any registration statement pursuant to the provisions of Sections 2.1 or 2.2
hereof shall be subject to the following further conditions: (a) should the
request for registration be pursuant to Section 2.1, and should the registration
statement proposed by the Company relate to an underwritten offering of
securities of the Company, and should the managing underwriter for the Company
inform the Company in writing that, in such underwriter's opinion, such
registration of all or a part of the Shares would materially impair the
Company's ability to sell the securities being registered by the Company, then
the Stockholders shall be entitled to participate pro rata with all other
stockholders entitled to registration rights ("Other Stockholders") based upon
the number of shares owned by or issuable to the Stockholders and each Other
Stockholders in the maximum amount of shares that such underwriter determines
may be sold without such impairment but in no event shall the amount of
securities of the selling Stockholders included in any such registration be
reduced below thirty percent (30%) of the total amount of securities included in
such registration, except for a registration relating to the Company's Initial
Public Registration, from which all securities of the selling Shareholder may be
excluded; (b) should the request for registration be pursuant to Section 2.2,
and should the managing underwriter inform the Company in writing that, in such
underwriter's opinion, the number of shares requested to be registered is more
than the number such underwriter reasonably expects can be sold upon acceptable
terms, then the Stockholders and the Other Stockholders shall be entitled to
participate pro rata, based upon the number of shares owned by or issuable to
each of them; (c) the Stockholders shall furnish to the Company in writing such
information and documents as, in the opinion of counsel to the Company, may be
reasonably required to properly prepare and file such registration statement in
accordance with applicable provisions of the Securities Act; and (d) if the
Stockholders desire to sell and distribute securities over a period of time, or
from time to time at the prevailing market prices pursuant to a registration
statement to be filed by the Company under the Securities Act, then the
Stockholders shall execute and deliver to the Company such written undertakings
as the Company and its counsel may reasonably require in order to assure full
compliance with relevant provisions of the Securities Act and the Exchange Act;
and (e) all Stockholders proposing to distribute their securities through such
underwriting shall (together with

                                      -4-
<PAGE>

the Company as provided in Section 2.4(e)) enter into and perform its
obligations under an underwriting agreement, in the usual and customary form,
with the underwriter or underwriters selected for such underwriting by a
majority in interest of the Initiating Stockholders and reasonably acceptable to
the Company.

          (b) Notwithstanding the foregoing, if the Company shall furnish to the
Initiating Stockholders, a certificate signed by the President or Chief
Executive Officer of the Company stating that in the good faith judgment of the
Board of Directors of the Company, it would be seriously detrimental to the
Company and its Stockholders for such registration statement to be filed and it
is therefore essential to defer the filing of such registration statement, then
the Company shall have the right to defer such filing for a period of not more
than 90 days after receipt of the request of the Initiating Stockholders;
provided, however, that the Company may not utilize this right more than once in
any twelve (12) month period.

          2.6  Notices of Registration Statements, Etc.  Except for the Initial
Public Registration, the Company shall not file any registration statement under
the Securities Act covering any debt or equity securities unless it shall first
have given the Stockholders written notice thereof and, if so requested by the
Stockholders, shall have consulted with the Stockholders concerning the
selection of underwriters, counsel and independent public accountants for the
Company and if, in the judgment of the Stockholders exercised in good faith, any
of the Stockholders are or might be deemed to be controlling persons of the
Company, the Company shall not file any such registration statement unless it
shall first have appointed underwriters, counsel, and independent public
accountants for the Company reasonably satisfactory to the Stockholders. A
Shareholder shall also have the right, at any time when, in its judgment
exercised in good faith, it is or might be deemed to be a controlling person of
the Company, to participate in the preparation of such registration statement
and to require the insertion therein of material that in its judgment, as
aforesaid, should be included, and at the expense of the Company to retain
counsel or independent public accountants or both to assist it in such
participation.

          2.7  Indemnity.

          (a) The Company agrees to indemnify and hold harmless the
Stockholders, their officers, directors and partners, as sellers of Shares, each
underwriter (within the meaning of the Securities Act) of such securities and
each person, if any, who controls (within the meaning of either Section 15 of
the Securities Act or Section 20 of the Exchange Act) any such seller,
controlling person or underwriter, from and against any losses, claims, damages
or liabilities, joint or several, that any such seller, underwriter or
controlling person may incur or to which any such seller, underwriter or
controlling person may become subject, under the Securities Act or otherwise,
insofar as such losses, claims, damages or liabilities (or actions in respect
thereof) arise out of or are based upon any untrue statement or alleged untrue
statement of any material fact contained in any preliminary prospectus, or
contained, on the effective date thereof, in any registration statement or final
or summary prospectus included therein, or any amendment or supplement thereto,
or arise out of or are based upon the omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the
statements therein not

                                      -5-
<PAGE>

misleading, or any violation or alleged violation of the Securities Act, the
Exchange Act or any rule or regulation promulgated under the Securities Act or
the Exchange Act (all such acts are hereinafter referred to as a "Violation");
and the Company will reimburse each such seller, underwriter or controlling
person for any legal or other expenses reasonably incurred by them in connection
with investigating or defending any such loss, claim, damage, liability or
action, whether or not resulting in liability; provided, however, the Company
will not be liable in any case to the extent that any such loss, claim, damage,
liability or expense arises out of or is based upon an untrue statement or
alleged untrue statement or omission or alleged omission made in such
registration statement, such preliminary, final or summary prospectus or such
amendment or supplement in reliance upon and in conformity with written
information furnished by or on behalf of any such seller specifically for use in
the preparation thereof.

          (b) Each seller of Shares will, severally and not jointly, indemnify
and hold harmless the Company, each of its directors, each of its officers who
sign or have signed said registration statement, each underwriter, each other
seller and each person, if any, who controls the Company or such underwriter or
seller (within the meaning of either Section 15 of the Securities Act or Section
20 of the Exchange Act), to the same extent as the foregoing indemnity from the
Company to such seller, insofar as such losses, claims, damages, or liabilities
(or actions in respect thereto) arise out of or are based upon any Violation, in
each case to the extent (and only to the extent) that such Violation occurs in
reliance upon and in conformity with written information furnished by such
seller of Shares expressly for use in connection with the preparation of such
registration statement, such preliminary, final or summary prospectus or such
amendment or supplement, and will reimburse the Company or any such director,
officer, underwriter or controlling person for any legal or other expenses
reasonably incurred by it in connection with investigating or defending any such
loss, claim, damage, liability or action, whether or not resulting in liability;
provided, however, that the indemnity agreement contained in this subsection
2.7(b) shall not apply to amounts paid in settlement of any such loss, claim,
damage, liability or action if such settlement is effected without the consent
of such seller, which consent shall not be unreasonably withheld; and, provided,
further, that, in no event shall any indemnity under this subsection 2.7(b)
exceed the gross proceeds from the offering received by such seller.

          (c) Promptly after receipt by an indemnified party of notice of the
commencement of any legal action against such indemnified party in respect of
which indemnity or reimbursement may be sought against the indemnifying party
under this Agreement, such indemnified party shall notify the indemnifying party
in writing of the commencement thereof, and, subject to the provisions
hereinafter stated, the indemnifying party shall assume the defense of such
action (including, the employment of counsel, who shall be counsel satisfactory
to such indemnified party, and the payment of expenses in connection therewith).
To the extent the Company and the indemnified party believe it prudent or
necessary, in their good faith discretion, such indemnified party shall, in
addition to the foregoing, have the right to employ separate counsel in any such
action and to participate in the defense thereof, and the fees and expenses of
such counsel shall be at the expense of the indemnifying party.  The
indemnifying party shall not be liable to indemnify any person for any
settlement of any such action effected without the consent of the indemnifying
party.  The failure to deliver written notice to the indemnifying party within a
reasonable time of the

                                      -6-
<PAGE>

commencement of any such action, if prejudicial to its ability to defend such
action, shall relieve such indemnifying party of any liability to the
indemnified party under this Section 2.7, but the omission so to deliver written
notice to the indemnifying party will not relieve it of any liability that it
may have to any indemnified party otherwise than under this Section 2.7.

          (d) In order to provide for just and equitable contribution in
circumstances in which the indemnification provided for above is due in
accordance with its terms but is held by a court to be unavailable on grounds of
policy or otherwise, the person or persons (individually, an "Indemnitor" and
collectively, the "Indemnitors") who would otherwise have been required to
indemnify any other person (the "Indemnitee") hereunder, shall contribute to the
aggregate losses, claims, damages, liabilities and expenses to which any such
Indemnitee may be subject in such proportion so that such Indemnitor is or such
Indemnitors, collectively, are responsible for that portion represented by the
percentage that the aggregate public offering price of the shares sold by such
Indemnitor or Indemnitors bears to the aggregate public offering price of all
shares sold in such registered offering; provided, however, that no person
adjudged guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) by a court of competent jurisdiction, in a final
judgment, shall be entitled to contribution from any person who was not adjudged
guilty of such fraudulent misrepresentation.  Any party entitled to contribution
shall, promptly after receipt of notice of the commencement of any action, suit
or proceeding against such party in respect of which a claim for contribution
may be made against another person hereunder, notify such other person, but the
omission to so notify another person shall not relieve such person from any
other obligation it may have hereunder or otherwise.

          (e) The indemnification of underwriters provided for in this Section
shall be on such other terms and conditions as are at the time customary and
reasonably required by such underwriters.

     3.   Expenses.  Except for underwritten discounts and commissions, the
Company shall pay any and all expenses incurred in connection with
registrations, filings, or qualifications required pursuant to the provisions
contained herein, including reasonable fees and expenses of one counsel for all
the Stockholders.

     4.   Reports Under the Exchange Act.  With a view to making available to
the Stockholders the benefits of Rule 144 promulgated under the Securities Act,
the Company agrees to use its best efforts: (i) to register under Section 12 of
the Exchange Act, not later than ninety (90) days after the end of the fiscal
year in which the first registration statement under the Securities Act filed by
the Company is declared effective, (ii) to file with the Commission in a timely
manner all reports and other documents required to be filed by an issuer of
securities registered under the Securities Act or the Exchange Act and (iii) so
long as the Stockholders own any of the Shares, to furnish in writing upon any
such Shareholder's request the following information:

          (a) The Company's name, address and telephone number;

          (b) The Company's Internal Revenue Service identification number;

                                      -7-
<PAGE>

          (c) The Company's Commission file number;

          (d) The number of shares of Common Stock outstanding as shown by the
most recent report or statement published by the Company; and

          (e) Whether the Company has filed all reports required to be filed by
Sections 13 or 15(d) of the Exchange Act during the preceding twelve (12)
months.  With respect to a rule or regulation of the Commission (other than Rule
144) that may at any time permit Stockholders to sell Shares to the public
without registration, the Company agrees to take such action as is reasonable to
enable utilization of such rule.

     5.   Transfer of Registration Rights.  The registration rights granted
hereunder may only be assigned (and only with all related obligations) by a
Stockholder in connection with a transfer of the Stockholder's Shares to an
affiliate (or other related entity) of such Stockholder or to a transferee who,
after such assignment or transfer holds at least 100,000 Shares. The Company
shall be given written notice by the Stockholders at the time of any such
transfer stating the name and address of the transferee and identifying the
Shares with respect to which the rights under this Agreement are being assigned.

     6.   Termination of Registration Rights.  The registration rights granted
pursuant to Section 2 of this Agreement shall terminate and be of no force and
effect as to any Stockholder and any subsequent transferee upon the earlier of
(a) the expiration of three (3) years from the initial public offering of the
Company's Common Stock and (b) when all Shares held or entitled to be held upon
conversion by such Stockholder may immediately be sold under Rule 144 during any
90-day period; provided, however, that with respect to the Registration Rights
granted pursuant to Section 2.2 herein, the provisions of this Section 6 shall
not apply to any holder who owns more than 2% of the Company's outstanding stock
until the earlier of (c) such time as such holder owns less than 2% of the
outstanding stock of the Company and (d) five years from the Company's Initial
Public Registration.

     7.   Future Registration Rights.  No future registration rights may be
granted without consent of the holders of a majority of the shares of Common
Stock issuable upon conversion of the outstanding Series B Preferred Stock,
Series C Preferred Stock and Series D Preferred Stock.

     8.   Modification and Waiver.  The parties may amend, modify or supplement
this Agreement in such manner as may be agreed upon by them in writing at any
time; provided, however, that no amendment, modification or supplement shall be
effective without the consent of the holders of at least 50% of the shares of
Common Stock issuable upon conversion of the outstanding Series B Preferred
Stock, Series C Preferred Stock and Series D Preferred Stock. Any party may by
an instrument in writing extend the time for or waive the performance of any of
the obligations of another party or waive compliance by another party with any
of the provisions contained herein. The failure of any party at any time or
times to require performance of any provision hereof shall in no manner affect
such party's right at a later date to enforce the same. No waiver by any party
of a breach of this Agreement, whether by conduct or otherwise, in any one or
more instances shall be, or shall be deemed to be, a further or continuing
waiver of such breach,

                                      -8-
<PAGE>

waiver of any condition or of any other breach of this Agreement. No waiver by
any one party to this Agreement shall be deemed to be a waiver of any other
party to this Agreement.

     9.   Notices.  Unless otherwise provided, any notice required or permitted
under this Agreement shall be given in writing and shall be deemed effectively
given the earlier of (i) when received, (ii) upon personal delivery to the party
to be notified, (iii) one business day after delivery via facsimile upon
appropriate confirmation, (iv) one day after being deposited with an overnight
courier service or (v) three days after deposit with the United States Post
Office, by registered or certified mail, postage prepaid and addressed to the
party to be notified at the address set forth on the signature page of this
Agreement, or at such other address as such party may designate by ten days
advance written notice to all other parties.

     10.  Gender and Number, Etc.  All words or terms used in this Agreement,
regardless of the number or gender in which they are used, shall be deemed to
include any other number and the other gender as the context may require.
"Hereof," "herein," and "hereunder" and words of similar import shall be
construed to refer to this Agreement as a whole, and not to any particular
paragraph or provisions, unless expressly so stated.

     11.  Successors and Assigns.  This Agreement shall not be assignable by any
party without the prior written consent of all other parties hereto or except
pursuant to Section 5 hereof, except that the Company may assign this Agreement
to a successor corporation pursuant to the reincorporation of the Company into
another state. Subject to the foregoing, all rights hereunder may be assigned or
otherwise conveyed to any such permitted transferee or assignee. Subject to the
foregoing, this Agreement shall be binding upon and inure to the benefit of the
respective successors and assigns of the parties hereto.

     12.  Counterparts.  This Agreement may be executed in any number of
counterparts with the same effect as if the signatures to each counterpart were
upon the same instrument.

     13.  Entire Agreement and Captions.  This Agreement sets forth the entire
understanding of the parties hereto and supersedes all prior agreements,
arrangements and communications, whether oral or written, between or among the
parties with respect to the subject matter hereof. Captions appearing in this
Agreement are for convenience of reference only and shall not be deemed to
explain, limit or amplify the provisions hereof.

     14.  Governing Law.  This Agreement shall be governed by and construed in
accordance with the laws of the State of Delaware.

     15.  Severability.  If any provisions contained in this Agreement shall for
any reason be held invalid, illegal or unenforceable in any respect, such
invalidity, illegality or unenforceability shall not invalidate the entire
Agreement. Such provision shall be deemed to be modified to the extent necessary
to render it valid and enforceable and if no such modification shall render it
valid and enforceable then the Agreement shall be construed as if not containing
such provision.

                                      -9-
<PAGE>

     16.  No Third Party Beneficiaries.  Nothing herein expressed or implied is
intended to confer upon any person, other than the parties hereto or their
respective permitted assigns, successors, heirs and legal representatives, any
rights, remedies, obligations or liabilities under or by reason of this
Agreement.

     17.  No Partnership or Joint Venture.  Notwithstanding anything to the
contrary contained herein, nothing contained herein shall be construed as
creating a partnership or joint venture relationship between the parties hereto,
and the parties hereto shall be deemed to have made any elections necessary
under any applicable law, rule or regulation to prevent their being considered
or deemed to be a partnership or joint venture.

     18.  No Impairment.  The Company will not take any action, or fail to take
any action, avoid or seem to avoid the observance or performance of any of the
terms to be performed by the Company hereunder and the Company will at all times
act in good faith to assist the Stockholders in the carrying out of the
provisions of this Agreement as may be necessary to preserve and protect the
registration rights of the Stockholders under this Agreement.

                                     -10-
<PAGE>

     This Amended and Restated Registration Rights Agreement is executed and
delivered on the day and year first above written.

"COMPANY"                 SONIC INNOVATIONS, INC.,
                          a Delaware corporation

                          /s/ William S. Barth
                          ------------------------------------------------
                          Signature of Authorized Signatory

                          William S. Barth, Vice President-Finance and CFO
                          ------------------------------------------------
                          Print Name and Title

"STOCKHOLDERS"            See Exhibit A
                          ------------------------------------------------
                          Print Name of Stockholder

                          ------------------------------------------------
                          Signature of Authorized Signatory

                          ------------------------------------------------
                          Print Name and Title

               AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

                                     -11-
<PAGE>

                                   EXHIBIT A

Series A Stockholders:

Mr. Jim Dreyfous
Utah Ventures Limited Partnership
423 Wakara Way, Suite 206
Salt Lake City, UT 84108

George M. Sims
535 East 5th Avenue
Salt Lake City, UT 84103

Carver A. Mead
Foveonics
10131 Bubb Rd., #B
Cupertino, CA 95014

New Era Investments
Attn: Nick S. Vidalakis
First Interstate Building
999 Third Avenue, Suite 1020
Seattle, WA 98104

Series B, Series C and/or Series D  Stockholders:

Jim Dreyfous                                    Accel Investors '95 L.P.
Utah Ventures Limited Partnership               Attn:  G. Carter Sednaoui
423 Wakara Way, Suite 1020                      One Palmer Square
Salt Lake City, UT 84108                        Princeton, NJ 08542

George M. Sims                                  Ellmore C. Patterson Partners
535 East 5th Avenue                             Attn:  G. Carter Sednaoui
Salt Lake City, UT 84103                        One Palmer Square
                                                Princeton, NJ 08542
Accel IV L.P.
Attn: G. Carter Sednaoui                        Venrock Associates
One Palmer Square                               Attn:  Anthony B. Evnin
Princeton, NJ 08542                             30 Rockefeller Plaza, #5508
                                                New York, NY 10112
Accel Keiretsu, L.P.
Attn:  G. Carter Sednaoui                       Venrock Associates II, L.P.
One Palmer Square                               Attn:  Anthony B. Evnin
Princeton, NJ 08542                             30 Rockefeller Plaza, #5508
                                                New York City, NY 10112

                                     -12-
<PAGE>

The Travelers Insurance Company          Calvert Social Venture Partners
Attn:  Daniel B. Kenney                  Attn:  John May
Securities 9 PB                          402 Maple Avenue West
205 Columbus Blvd., Loading Dock         Vienna, VA 22180
Hartford, CT 06183-2030
                                         Labrador Ventures II, L.P.
The Travelers Indemnity Company          Attn:  Stuart Davidson
Attn:  Daniel B. Kenney                  400 Seaport Court, Suite 250
Securities 9 PB                          Redwood City, CA 94063
205 Columbus Blvd., Loading Dock
Hartford, CT 06183-2030                  Effie E. Westervelt Revocable Trust
                                         26 Southridge, E
The Travelers Life and Annuity Company   Tiburon, CA 94920
Attn:  Daniel B. Kenney
Securities 9 PB                          Effie E. Westervelt
205 Columbus Blvd., Loading Dock         26 Southridge, E
Hartford, CT 06183-2030                  Tiburon, CA 94920

The Phoenix Insurance Company            Harry A. George
Attn:  Daniel B. Kenney                  Solstice Capital
Securities 9 PB                          13651 E. Camino La Cebadilla
205 Columbus Blvd., Loading Dock         Tucson, AZ 87549
Hartford, CT 06183-2030
                                         Patricia H. Highberg
New Era Investments                      Randall Road
Attn:  Nick Vidalakis                    Off Church Hill
First Interstate Building                Woodstock, VT 05091
999 Third Avenue, Suite 1020
Seattle, WA 98104                        Carol H. Tolan
                                         200 E. 89th Street
California Institute of Technology       New York, NY 10128
Attn:  Sandra Ell
551 South Wilson Avenue                  Arno Penzias
Pasadena, CA 91125                      1960 Grant Ave.
                                         San Francisco, CA 94133
PV Securities Corporation
Attn:  Phil Villers                      Morgenthaler Venture Partners IV
97 Lowell Road                           Attn:  Mr. Gary Schaffer
Suite 11-4                               2730 Sand Hill Road, Suite 280
Concord, MA 01742                        Menlo Park, CA 94025

PV Securities Corp.                      New Enterprise Associates VII, Ltd.
20 Whit's End Road                       Attn: Ms. Sigrid Van Bladel
Concord, MA 07142                        2490 Sand Hill Road
                                         Menlo Park, CA 94025
<PAGE>

NEA Presidents Fund, L.P.               BB BioVentures LP
Attn: Ms. Sigrid Van Bladel             Attn: Luke Evnin
2490 Sand Hill Road                     1 Cambridge Center
Menlo Park, CA 94025                    9th Floor
                                        Cambridge, MA 02142
NEA Ventures 1997, Limited Partnership
Attn: Ms. Sigrid Van Bladel             MPM Asset Management Investors 1998 LLC
2490 Sand Hill Road                     Attn: Luke Evnin
Menlo Park, CA 94025                    1 Cambridge Center
                                        9th Floor
Joshua Mailman                          Cambridge, MA 02142
Sirius Business Corp.
150 East 58th Street                    MPM Bioventures Parallel Fund LP
New York, NY 10155                      Attn: Luke Evnin
                                        1 Cambridge Center
                                        9th Floor
                                        Cambridge, MA 02142<PAGE>

                                                                    EXHIBIT 10.6

                            SONIC INNOVATIONS, INC.

                                     AND

                          STARKEY LABORATORIES, INC.

                                OEM AGREEMENT

                                April 19, 1999

[ * ]= CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED
SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH
RESPECT TO THE OMITTED PORTIONS.

<PAGE>

                                 OEM AGREEMENT

          This OEM AGREEMENT, including the attached Exhibits (the "Agreement"),
                                                                    ---------
made and entered into as of April 1, 1999 (the "Effective Date"), is by and
                                                --------------
between Sonic Innovations, Inc. ("Sonic"), a Delaware corporation with an office
                                  -----
at 5330 S 900 East, Ste. 240, Salt Lake City, Utah 84117, and Starkey
Laboratories, Inc. ("Starkey"), a Minnesota corporation with an office at 6600
                     -------
Washington Ave., So., Eden Prairie, Minnesota 55344 (each of Sonic and Starkey,
a "Party"; together, the "Parties").
   -----                  -------

                                   BACKGROUND
                                   ----------

          A.  Sonic is engaged in the business of manufacturing, distributing,
and selling Hybrids (as defined below) for use in hearing aid devices and other
products; and

          B.  Starkey desires to purchase Hybrids from Sonic, and distribute and
sell Products (as defined below) to, customers in the Territory (as defined
below); and

          C.  Starkey desires to purchase from Sonic, and Sonic desires to sell
to Starkey, such Hybrids for the purpose of incorporating the same into Products
for resale to customers in the Territory.

          NOW, THEREFORE, in consideration of the mutual promises contained
herein, the Parties agree as follows:

1.  DEFINITIONS.
    -----------

          1.1  "Date Code" shall mean the date of manufacture of each Hybrid
                ---------
manufactured and sold by Sonic.

          1.2  "Hybrid" shall mean Sonic's proprietary integrated circuit for
                ------
digital signal processing as it exists as of the Effective Date.

          1.3  "Product(s)" shall mean Starkey's proprietary hearing aid product
                ----------
which incorporates a Hybrid.

          1.4  "Reliability Specification" shall mean the reliability
                -------------------------
specification documents numbers 99012-008 (Effective Date 7/9/95), Rev. A and
99012-006 (Effective Date 7/9/95), Rev. A, as provided by Starkey to Sonic and
attached hereto as Exhibit C.

          1.5  "Specifications" shall mean the specifications for the use and
                --------------
operation of the Hybrid as set forth in Exhibit A.

                                      -1-
<PAGE>

          1.6  "Starkey Affiliate" shall mean, with respect to Starkey, a
                -----------------
corporation, company or other entity that is owned or controlled by Starkey by
virtue of Starkey's direct or indirect ownership or control of more than fifty
percent (50%) of the outstanding shares or securities (representing the right to
vote for the election of directors or other managing authority) of such
corporation, company or other entity, but such corporation, company or other
entity shall be deemed to be a Starkey Affiliate only so long as such ownership
or control exists.

          1.7  "Term" shall have the meaning set forth in Section 11.1.
                ----

          1.8  "Territory" shall mean, until October 1, 1999, any country
                ---------
outside the United States of America and its territories in which Starkey
operates wholly-owned manufacturing or distribution facilities; provided,
however, that after October 1, 1999, the Territory shall expand to include such
entities within the United States of America and its territories.

2.  GRANT OF OEM RIGHTS.
    -------------------

          2.1  Appointment. Subject to the terms and conditions of this
               -----------
Agreement, Sonic hereby grants to Starkey and Starkey Affiliates the non-
exclusive rights to (i) manufacture Products, and (ii) market, sell and
distribute Products to end user customers in the Territory.

          2.2  Sale Conveys No Right to Manufacture or Modify. The Hybrids are
               ----------------------------------------------
offered for sale and are sold by Sonic subject in every case to the condition
that (i) except as necessary to program such Hybrid for a particular end-user,
such sale does not convey any license, expressly or by implication, to modify,
duplicate, reverse engineer or otherwise copy or reproduce any of the Hybrids,
(ii) Starkey and Starkey Affiliates shall use each Hybrid only as incorporated
into and sold as part of a Product and for no other purpose whatsoever, (iii)
Starkey and Starkey Affiliates shall not use Hybrids for any purpose except to
manufacture and service Products, and (iv) Starkey and Starkey Affiliates will
not sell or otherwise distribute Hybrids except incorporated into a Product.

          2.3  Reservation of Rights; No Rights Beyond OEM Rights. Except as
               --------------------------------------------------
expressly provided in this Article 2, (i) no right, title, or interest is
granted, whether express or implied, by Sonic to Starkey or a Starkey Affiliate,
(ii) nothing in this Agreement shall be deemed to grant to Starkey or a Starkey
Affiliate rights in any products or technology other than the Hybrids, and (iii)
no provision of this Agreement shall be deemed to restrict Sonic's right to
exploit technology, know-how, patents, or any other intellectual property
rights.

3.  PRICE AND PAYMENT.
    -----------------

               3.1  Hybrid Prices.  Starkey shall pay to Sonic the sum of [ * ]
                    -------------
for each Hybrid that it receives from Sonic.

[ * ]= CERTAIN INFORMATION ON THIS PAGE HAS BEEN OMITTED AND FILED SEPARATELY
WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO
THE OMITTED PORTIONS.

                                      -2-
<PAGE>

          3.2  Payment.
               -------

               (a) Sonic shall invoice Starkey and Starkey shall make payments
to Sonic under this Agreement in United States dollars in immediately available
funds to a bank account designated by Sonic by wire transfer as follows: [Sonic
to provide]. All payments made hereunder shall be paid in full, without any
deduction of taxes or charges of any kind, except to the extent that a
governmental authority imposes income taxes or other taxes on payments made to
Sonic pursuant to this Agreement. In the event that such taxes must be paid by
Starkey, then Starkey may deduct such taxes from the payment and send Sonic tax
payment certificates, receipts, and other such supporting data and to take other
reasonable acts as may be requested by Sonic to establish that such taxes have
been deducted and paid by Starkey on behalf of Sonic. Starkey shall cooperate
with Sonic to aid Sonic to recover any such taxes paid.

               (b) Payment for Hybrids supplied subject to Section 3.1 shall be
made net thirty (30) days after the date of shipment of the relevant Hybrids by
Sonic to Starkey.

               (c) Any payments due hereunder which are not paid within five (5)
days of the date such payments are due in accordance with Section 3.2(b) shall
bear interest at the lesser of one and one-half percent (1-1/2%) per month or
the maximum rate permitted by law, calculated on the number of days such payment
is delinquent. This Section 3.2(c) shall in no way limit any other remedies
available to Sonic.

4.  TERMS OF PURCHASE AND SALE.
    ---------------------------

               4.1  Minimum Annual Order.  Upon Starkey's successful evaluation
                    --------------------
of the Hybrid and calibration test systems, which evaluation period will end no
later than May 31, 1999, Starkey shall place a binding purchase order with Sonic
for a minimum of [ * ] Hybrids to be delivered no later than twelve (12) months
after the Effective Date.

               4.2  Forecasts.  On the ninetieth (90/th/) day prior to the first
                    ---------
(1/st/) anniversary of the Effective Date, and every year thereafter during the
Term, Starkey shall provide to Sonic a [non-binding] written forecast of the
number of Hybrids that Starkey expects to purchase over the subsequent twelve
(12) months ("Forecasts").

               4.3  Order and Acceptance.   All orders for Hybrids shall be made
by signed written purchase orders by Starkey to a Sonic employee designated in
writing by Sonic, sent to Sonic at Sonic's address for notice hereunder and
proposing a delivery date that is consistent with the Forecasts and not less
than sixty (60) days after Sonic's receipt of such purchase order. To the extent
that any one purchase order exceeds [  *  ] Hybrids, such purchase order must be
submitted to Sonic at least ninety (90) days in advance of any requested
delivery date. Orders shall be placed by a signed written purchase order, which
may be provided to Sonic by fax. Sonic shall accept or reject purchase orders by
fax or in writing within seven (7) days of receipt, it being understood that no
purchase order shall be binding upon Sonic until accepted by Sonic. Sonic shall
fulfill purchase orders accepted by Sonic pursuant to the terms and conditions
of this Agreement.

[ * ]= CERTAIN INFORMATION ON THIS PAGE HAS BEEN OMITTED AND FILED SEPARATELY
WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO
THE OMITTED PORTIONS.

                                      -3-
<PAGE>

No partial shipment of an order shall constitute the acceptance of the entire
order, absent the written acceptance of such entire order. Once accepted by
Sonic, Starkey may cancel or reschedule purchase orders for Hybrids only with
Sonic's prior written approval.

    4.4  Invoicing. Sonic shall submit an invoice to Starkey upon shipment by
         ---------
Sonic of Hybrids ordered by Starkey. Each such invoice shall state Starkey's
aggregate price for Hybrids in a given shipment, plus any freight, taxes or
other costs incident to the purchase or shipment initially paid by Sonic but to
be borne by Starkey hereunder.

    4.5  Shipping.  All Hybrids delivered pursuant to the terms of this
         --------
Agreement shall be suitably packed for surface or air shipment, in Starkey's
discretion, in Sonic's standard shipping cartons, and delivered, at Starkey's
direction, to Starkey or a carrier agent FCA (per Incoterms, ICC Ed. 1990) the
shipping location designated by Starkey (the "Shipping Location"), at which time
                                              -----------------
risk of loss shall pass to Starkey.  Sonic shall ship Hybrids using the carrier
specified in Starkey's purchase order provided that if Starkey does not provide
instructions with respect to the carrier to be used, Sonic shall select the
carrier.  All freight, insurance, and other shipping expenses, as well as any
special packing expenses incurred by Sonic at the request of Starkey, shall be
paid by Starkey.  Starkey shall also bear all applicable taxes, export taxes,
duties and similar charges, and any charges that may be assessed against the
Hybrids after delivery to Starkey or the carrier at the Shipping Location.  All
shipments and freight charges shall be deemed correct unless Sonic receives from
Starkey, no later than forty-five (45) days after the shipping date of a given
shipment, a written notice specifying the shipment, the purchase order number,
and the exact nature of the discrepancy between the order and shipment or
discrepancy in the freight cost, as applicable.  To the extent that there is any
conflict between any invoice or purchase order delivered hereunder and the terms
and conditions of this Agreement, the terms and conditions of this Agreement
shall control as to such conflict.

    4.6  Returns.  Except as set forth in Article 5 below, Starkey may return
         -------
Hybrids only with Sonic's prior written approval. Hybrids returned to Sonic
other than under Article 7 shall be returned FCA (per Incoterms, ICC Ed. 1990)
the destination point designated by Sonic and shall be subject to a restocking
fee in an amount equal to five percent (5%) of the price paid by Starkey to
Sonic for such Hybrid as set forth in Section 3.1. Starkey shall also bear all
applicable taxes, export taxes, duties and similar charges, and any charges that
may be assessed against the Products in connection with such delivery to Sonic
at the destination point.

5.  ACCEPTANCE.  Starkey shall inspect all Hybrids promptly upon receipt thereof
    ----------
and may reject any Hybrid [that fails to conform to the warranties set forth in
Article 7 below at the time of delivery to Starkey,] provided that Starkey
notifies Sonic of such non-conformity within thirty (30) days of delivery.
Except as set forth in this Article 5 and Article 7 below, Starkey shall return
Hybrids to Sonic only with Sonic's prior written approval.

6.  SONIC MANUFACTURING CALIBRATION SYSTEM.  In order to permit Starkey to test
    --------------------------------------
and calibrate Products, Sonic shall sell to Starkey units of its Sonic
Manufacturing Calibration System at Sonic's cost.  Such sale is made subject to
the condition that (i) such sale does not convey

                                      -4-
<PAGE>

any license, expressly or by implication, to modify, duplicate, reverse
engineer, or otherwise copy or reproduce the Sonic Manufacturing Calibration
System, and (ii) Starkey shall not make any other use of the Sonic Manufacturing
Calibration System other than to test Hybrids sold by Sonic to Starkey pursuant
to this Agreement.

7.        LIMITED WARRANTY.
          ----------------

          7.1  Hybrid Limited Warranty.  Sonic warrants to Starkey that, subject
               -----------------------
to the exclusions set forth in this Section 7.1 and in Section 7.2 below, for a
period of one hundred twenty (120) days following delivery to Starkey, Hybrids
manufactured and delivered hereunder shall:  (i) substantially conform to the
Specifications and the Reliability Specification; (ii) be manufactured in
accordance with good manufacturing practices and standards established in the
trade; and (iii) be manufactured in accordance with all applicable laws,
regulations, rules and governmental directives.  The foregoing warranty is
contingent upon proper use of the Hybrid in the applications for it was intended
as indicated in the Specifications.  The above limited warranty applies only to
defects reported to Sonic in accordance with Sonic's standard reporting
procedures [described in the Specifications] and does not apply to any Hybrid
which after dispatch from the Shipping Location (i) has been altered or subject
to undue electrical or mechanical force or stresses, (ii) has not been
maintained in accordance with any transportation, storage, handling or
maintenance instructions supplied by Sonic, (iii) has been damaged by negligence
or accident, or (iv) has been damaged by acts of nature, vandalism, burglary,
neglect, or misuse.  In the event of any breach of the above limited warranty
and provided that the Parties agree to upon a Return Merchandise Authorization
(an "RMA"), Starkey's exclusive remedy and Sonic's sole and exclusive liability
     ---
shall be, at Sonic's sole election, to replace the Hybrid at Sonic's expense or
to provide Starkey with a credit or refund in the amount of the price paid by
Starkey for the non-conforming Hybrid(s) properly assigned an RMA.

          7.2  Disclaimer of Other Warranties.  EXCEPT FOR THE LIMITED
               ------------------------------
WARRANTIES PROVIDED IN SECTION 7.1 ABOVE, SONIC GRANTS NO OTHER WARRANTIES OR
CONDITIONS, EXPRESS OR IMPLIED, BY STATUTE, OR OTHERWISE, REGARDING THE HYBRID,
AND SONIC SPECIFICALLY DISCLAIMS THE IMPLIED WARRANTIES OF FITNESS FOR A
PARTICULAR PURPOSE, MERCHANTABILITY, AND NONINFRINGEMENT.  SONIC DISCLAIMS ANY
WARRANTY THAT OPERATION OF THE HYBRID WILL BE UNINTERRUPTED OR ERROR-FREE.  ANY
OTHER REPRESENTATIONS OR WARRANTIES MADE BY ANY PERSON OR ENTITY, INCLUDING
EMPLOYEES OR REPRESENTATIVES OF SONIC, THAT ARE INCONSISTENT HEREWITH SHALL BE
DISREGARDED AND SHALL NOT BE BINDING UPON SONIC.

8.        EXCHANGE OF DATA; GOVERNMENTAL APPROVAL.
          ---------------------------------------

          8.1  Exchange.  Starkey shall promptly provide to Sonic all [technical
               --------
and/or clerical] data made, developed, or acquired by or for Starkey with
respect to the Hybrid.  Sonic shall provide to Starkey access to data from
Hybrid studies that Sonic possesses as of the Effective Date, or develops or
acquires during the Term, and that is reasonably necessary for Starkey to obtain
those

                                      -5-
<PAGE>

governmental approvals that Starkey is responsible for obtaining pursuant to
this Article 8 below, to the extent that Sonic has the right to disclose such
data to Starkey for the foregoing purposes and subject to Article 13 below.

          8.2  Disclosure.  Starkey will only use, reference, and disclose Data
               ----------
relating to the Hybrid to third parties as required to obtain governmental
approval to market and distribute Products pursuant to this Article 8, as
required by law, or, to the extent Sonic has the right to authorize Starkey to
do so and only with Sonic's prior written approval which shall not be
unreasonably withheld, to market and promote the Products, in each case subject
to Article 13 below.

          8.3  Health Regulatory Approval.  Starkey, at Starkey's expense, shall
               --------------------------
be responsible for obtaining regulatory approvals from [the U.S. Food and Drug
Administration] and its foreign equivalents in the Territory to the extent
required by the foregoing regulatory authorities to sell and distribute the
Products in the Territory.

          8.4  Registrations, Licenses and Permits.  Starkey, at Starkey's
               -----------------------------------
expense, shall obtain all registrations, licenses, and permits required to
comply with the laws and regulations within the Territory for sale and
distribution of the Products.

9.        ADDITIONAL OBLIGATIONS OF STARKEY.
          ---------------------------------

          9.1  Translation.  Starkey shall at its cost provide any and all
               -----------
resources necessary to translate all manuals, instructions, literature, and
package insert data sheets relating to the Hybrid for use in the Territory.

          9.2  Business Obligations.  Any and all obligations associated with
               --------------------
Starkey's business shall remain the sole responsibility of Starkey.  Any and all
sales and other agreements between Starkey and its customers are and shall
remain Starkey's exclusive responsibility and shall have no effect on Starkey's
obligations pursuant to this Agreement.

          9.3  Foreign Corrupt Practices Act.  In conformity with the United
               -----------------------------
States Foreign Corrupt Practices Act, Starkey and its employees and agents shall
not directly or indirectly make any offer, payment, promise to pay, or authorize
payment, or offer a gift, promise to give, or authorize the giving of anything
of value for the purpose of influencing an act or decision of an official of any
government within the Territory or the United States Government (including a
decision not to act) or inducing such official to use his influence to affect
any such governmental act or decision in order to assist Sonic in obtaining,
retaining, or directing any such business.

          9.4  Custom Fitting.  Except as otherwise permitted in this Agreement,
               --------------
Starkey shall not, nor allow any third party to, make any use of or otherwise
attempt to copy Sonic's proprietary Best Fit Fast/TM/ and ExpressFit/TM/ custom
fitting system.

                                      -6-
<PAGE>

          9.5  Advertising and Promotions.  Starkey shall not make any reference
               --------------------------
in its marketing or sales literature to the following:  Natura/TM/, Sonic
innovations, or Best Fit Fast/TM/, ExpressFit/TM/ or any other promotional
materials used by Sonic in the sales and marketing of the Natura/TM/.

          9.6  Product Packaging, Patent Marking, and Labeling.  Starkey shall
               -----------------------------------------------
label the Products with the Starkey tradename and trademarks and the Starkey
tradename and trademarks only, and Starkey shall not label the Products with any
of the following proprietary Sonic marks:  Natura/TM/, Sonic innovations, or
Best Fit Fast/TM/, ExpressFit/TM/ or any other trademark of Sonic unless
required by applicable law.  Starkey shall mark all Products it sells or
distributes pursuant to this Agreement in accordance with the applicable patent
statute or regulations in the country or countries of manufacture and sale
thereof, including with those patent numbers listed on Exhibit B.

          9.7  No Reverse Engineering.  Starkey shall not, nor shall it allow
               ----------------------
any third party to, disassemble or reverse engineer the Hybrid or decompile or
otherwise attempt to obtain to the source code from the object code of any
software embedded on any Hybrid.

10.       REPORTS. Pursuant to the FDA's Medical Device Reporting (MDR)
          -------
Regulations, Sonic and/or Starkey may be required to report to the FDA
information that reasonably suggests that a Hybrid may have caused or
contributed to a death or serious injury or has malfunctioned and that the
device would be likely to cause or contribute to a death or serious injury if
the malfunction were to recur. The Parties agree to supply to each other any
such information regarding Hybrids used in Products promptly after becoming
aware of it so that each party can comply with its own governmental reporting
requirements.

11.       TERM AND TERMINATION.
          --------------------

          11.1  Term.  The term of this Agreement shall commence on the
                ----
Effective Date and continue in full force and effect until three (3) years from
the Effective Date, unless earlier terminated pursuant to this Article 11 (such
period, the "Term"); provided that after the Term, the Agreement will
             ----
automatically renew for additional one (1) year periods unless either Party
provides written notice of its intent not to renew at least one hundred eighty
(180) days prior to the expiration of the Term or such additional one (1) year
period.

          11.2  Termination for Convenience.  Either party may terminate this
                ---------------------------
Agreement for its convenience upon one hundred eighty (180) days written notice
to the other.

          11.3  Termination for Cause.  Either Sonic or Starkey may terminate
                ---------------------
this Agreement by written notice stating its intent to terminate in the event
the other shall have breached or defaulted in the performance of any of its
material obligations hereunder, and such default shall have continued for sixty
(60) days after written notice thereof was provided to the breaching party by
the non-breaching party.  In addition, Sonic may terminate this Agreement by
written notice in the event Starkey does not pay Sonic in accordance with the
provisions of Section 3.2 and such failure shall have continued for ten (10)
days after written notice thereof was provided to Starkey by Sonic.

                                      -7-
<PAGE>

Further, Sonic may terminate this Agreement immediately upon written notice in
the event of any breach or threatened breach by Starkey of any of Sections 2,
9.4, 9.5, 9.6, or 9.7.

          11.4  Termination for Infringement. Starkey may terminate this
                ----------------------------
Agreement immediately upon notice if (i) a court of competent jurisdiction
determines in a non-appealable final judgment that the Hybrid infringes the
Intellectual Property rights of a third party, or (ii) the use, manufacture,
sale, offer for sale or import of Hybrids is enjoined as the result of such
Hybrid's infringement of a third party's Intellectual Property rights.

          11.5  Termination for Bankruptcy.  Either party may terminate this
                --------------------------
Agreement effective upon written notice to the other party in the event the
other party declares bankruptcy or becomes the subject of any voluntary or
involuntary proceeding under the U.S. Bankruptcy Code or any state insolvency
proceeding, and such proceeding is not terminated within one hundred twenty
(120) days of its commencement.

          11.6  Effect of Termination.
                ---------------------

               (a) Expiration or termination of this Agreement for any reason
shall not release any party hereto from any liability which, at the time of such
termination, has already accrued to the other party or which is attributable to
a period prior to such termination nor preclude either party from pursuing any
rights and remedies it may have hereunder or at law or in equity with respect to
any breach of this Agreement. It is understood and agreed that monetary damages
may not be a sufficient remedy for any breach of this Agreement and that the
non-breaching party may be entitled to injunctive relief as a remedy for any
such breach. Such remedy shall not be deemed to be the exclusive remedy for any
such breach of this Agreement, but shall be in addition to all other remedies
available at law or in equity.

               (b) Within thirty (30) days after the effective date of
termination of this Agreement, Starkey shall use its reasonable efforts to
provide Sonic with a complete inventory of Hybrids in Starkey's possession, in
transit to Starkey from Sonic or otherwise in Starkey's control. Starkey's
rights under Article 2 shall survive to the extent reasonably necessary for
Starkey to dispose of all such Hybrids pursuant to the terms and conditions of
this Agreement. Upon any expiration or other termination of this Agreement,
Sonic may inspect Starkey's Hybrid inventory. [Sonic may at cost repurchase any
inventory of Hybrids in Starkey's possession.]

               (c) Repairs or Replacement. Upon termination of this Agreement
                   ----------------------
and for five (5) years thereafter, Sonic shall agree to provide repair or
replacement Hybrids for sale to Starkey; provided that, (i) such repair or
replacement Hybrid is distributed to Starkey or a Starkey Affiliate end-user
customer who purchased a Product prior to the end of the Term and solely for the
purpose of repairing, replacing or servicing such Product.

          11.7  No Renewal, Extension or Waiver.  Acceptance of any order from,
                -------------------------------
or sale of, any Hybrid to Starkey after the date of termination of this
Agreement or pursuant to Section 11.6(c) shall not be construed as a renewal or
extension hereof, or as a waiver of termination by Sonic.

                                      -8-
<PAGE>

    11.8  Limitation of Liability Upon Termination.  In the event of termination
          ----------------------------------------
by either party in accordance with any of the provisions of this Agreement,
neither party shall be liable to the other, because of such termination, for
compensation, reimbursement or damages on account of the loss of prospective
profits or anticipated sales or on account of expenditures, inventory,
investments, leases or commitments in connection with the business or goodwill
of Sonic or Starkey.

    11.9  Survival of Certain Terms.  The provisions of Articles 7, 12, 13, 14,
          -------------------------
15, and Sections 11.6, 11.8, and 11.9 shall survive termination for any reason.

12.  LIMITATION OF LIABILITY.
     -----------------------

     SONIC'S ENTIRE LIABILITY ARISING OUT OF THIS AGREEMENT AND/OR THE SALE OF
HYBRIDS SHALL BE LIMITED TO THE AGGREGATE AMOUNTS PAID BY STARKEY TO SONIC FOR
THE PRODUCTS UNDER THIS AGREEMENT. IN NO EVENT SHALL EITHER PARTY BE LIABLE FOR
COSTS OF PROCUREMENT OF SUBSTITUTE GOODS BY ANYONE. IN NO EVENT SHALL EITHER
PARTY BE LIABLE TO THE OTHER PARTY OR ANY OTHER PERSON FOR ANY SPECIAL,
CONSEQUENTIAL OR INCIDENTAL DAMAGES, HOWEVER CAUSED AND ON ANY THEORY OF
LIABILITY ARISING OUT OF THIS AGREEMENT, AND WHETHER OR NOT SUCH PARTY HAS BEEN
ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. THESE LIMITATIONS SHALL APPLY
NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED
HEREIN. NOTWITHSTANDING THE FOREGOING PROVISIONS OF THIS ARTICLE 12, THE
FOREGOING LIMITATIONS OF LIABILITY SET FORTH IN THIS ARTICLE 12 SHALL NOT APPLY
TO LIABILITY ARISING UNDER ARTICLES 13 OR 14 OR SECTION 2.3, AND SHALL NOT
DIMINISH THE REMEDIES EXPRESSLY PROVIDED IN ARTICLE 7.

13.  CONFIDENTIALITY.
     ---------------

     13.1  Confidential Information.  Except as expressly provided herein, the
           ------------------------
parties agree that, for the Term of this Agreement and for seven (7) years
thereafter, the receiving party shall not publish or otherwise disclose and
shall not use for any purpose, except as expressly permitted herein any
information furnished to it by the other party hereto pursuant to this Agreement
which if disclosed in tangible form is marked "Confidential" or with other
similar designation to indicate its confidential or proprietary nature, or if
disclosed orally is confirmed as confidential or proprietary by the party
disclosing such information at the time of such disclosure or within thirty (30)
days thereafter ("Confidential Information"). Notwithstanding the foregoing, it
is understood and agreed that Confidential Information shall not include
information that, in each case as demonstrated by written documentation:

                (a) was already known to the receiving party, other than under
an obligation of confidentiality, at the time of disclosure;

                                      -9-
<PAGE>

                (b) was generally available to the public or otherwise part of
the public domain at the time of its disclosure to the receiving party;

                (c) became generally available to the public or otherwise part
of the public domain after its disclosure and other than through any act or
omission of the receiving party in breach of this Agreement; or

                (d) was subsequently lawfully disclosed to the receiving party
by a person other than a party hereto or developed by the receiving party
without reference to any information or materials disclosed by the disclosing
party.

          13.2  Confidentiality of Agreement.  Each Party agrees that the terms
                ----------------------------
and conditions, but not the existence, of this Agreement shall be treated as the
other's Confidential Information and that no reference to the terms and
conditions of this Agreement or to activities pertaining thereto can be made in
any form of public or commercial advertising without the prior written consent
of the other Party; provided, however, that each Party may disclose the terms
                    --------  -------
and conditions of this Agreement:  (i) as required by any court or other
governmental body; (ii) as otherwise required by law; (iii) to legal counsel of
the Parties; (iv) in connection with the requirements of an initial public
offering or securities filing; (v) in confidence, to accountants, banks, and
financing sources and their advisors; (vi) in confidence, in connection with the
enforcement of this Agreement or rights under this Agreement; or (vii) in
confidence, in connection with a merger or acquisition or proposed merger or
acquisition, or the like.

          13.3  Compelled Disclosure.  If a Receiving Party believes that it
                --------------------
will be compelled by a court or other authority to disclose Confidential
Information of the Disclosing Party, it shall give the Disclosing Party prompt
written notice so that the Disclosing Party may take steps to oppose such
disclosure.

14.  INDEMNIFICATION.
     ---------------

          14.1  Indemnification of Starkey.
                --------------------------

                (a) Sonic shall indemnify, defend, and hold harmless Starkey and
the Starkey Affiliates and their respective directors, officers, employees, and
agents, and the successors and assigns of any of the foregoing (the "Starkey
Indemnitees") from and against all claims, losses, costs, and liabilities
(including, without limitation, payment of reasonable attorneys' fees and other
expenses of litigation), and shall pay any damages (including settlement
amounts) finally awarded with respect to claims, suits, or proceedings (any of
the foregoing, a "Claim") brought by third parties against a Starkey Indemnitee,
caused by (a) a failure by Sonic to manufacture the Hybrid in accordance with
the Specifications, (b) breach of any representation made by Sonic hereunder, or
(c) the negligence or willful misconduct of Sonic, except to the extent such
Claim is covered under Section 14.2 below or is caused by the negligence or
willful misconduct of a Starkey Indemnitee.

                                     -10-
<PAGE>

          (b) Starkey agrees that Sonic has the right to defend, or at its
option to settle, and Sonic agrees, at its own expense, to defend or at its
option to settle, any claim, suit or proceeding brought against Starkey by any
third party for infringement of any U.S. or foreign patents or copyright by the
Hybrid arising out of or in connection with this Agreement, and Sonic agrees to
indemnify, defend and hold harmless the Starkey Indemnitees (as defined in
Section 14.1(a) above) from and against any and all claims, losses, damages,
costs and liabilities (including payment of reasonable attorneys fees and other
expenses of litigation) arising from such infringement claim and shall pay any
damages finally awarded with respect to such a claim, suit or proceeding.
Notwithstanding the provisions of this Section 14.1(b), Sonic assumes no
liability for (i) any combination of Hybrid with other products not provided by
Sonic, which infringement would not arise from the Hybrid standing alone, or
(ii) the modification of the Hybrid by Starkey or any third party where such
infringement would not have occurred but for such modifications.
Notwithstanding the foregoing, if it is adjudicatively determined that the
Hybrid infringes, or in Sonic's sole opinion, may be found to infringe a third
party's patent or copyright, or if the sale or use of the Products is, as a
result of such infringement, enjoined, then Sonic may, at its sole option and
expense either:  (i) replace the Hybrid with other noninfringing functionally
equivalent integrated circuits; or (ii) modify the Hybrid to make the Hybrid
functionally equivalent and noninfringing; or (iii) if (i) - (ii) are deemed
commercially impracticable by Sonic, discontinue sales of the Hybrid to Starkey
under this Agreement.  THE FOREGOING PROVISIONS OF THIS SECTION 14.1(b) STATE
THE ENTIRE LIABILITY OF SONIC AND THE EXCLUSIVE REMEDY OF STARKEY WITH RESPECT
TO ANY ALLEGED INFRINGEMENT OF THIRD PARTY PATENTS, COPYRIGHTS, TRADEMARKS OR
OTHER INTELLECTUAL PROPERTY RIGHTS BY THE HYBRID OR ANY PART THEREOF OR THE USE
OF EITHER.

          14.2  Indemnification of Sonic.  Starkey shall indemnify, defend, and
                ------------------------
hold harmless Sonic, and its Affiliates and their respective directors,
officers, employees and agents, and the successors, and assigns of any of the
foregoing (the "Sonic Indemnitees") from and against all claims, losses, costs,
and liabilities (including, without limitation, payment of reasonable attorneys'
fees and other expenses of litigation), and shall pay any damages (including
settlement amounts) finally awarded with respect to a Claim brought by third
parties against a Sonic Indemnitee, arising out of or relating to (a) acts or
omissions of Starkey in the distribution or marketing of Products; (b) breach of
any of the representations or warranties made by Starkey hereunder, (c) a claim
that the Product infringes any intellectual property rights of a third party,
except in each case to the extent such claim is covered under Section 14.1, (d)
any failure by Starkey to obtain any applicable governmental approvals or
licenses required for the marketing and distribution of the Products, (e) a
claim relating to the manufacture or operation of the Product to the extent that
such claim is not due solely to a manufacturing defect in the Hybrid, or (f) the
negligence or willful misconduct of Starkey, except, in each case, to the extent
such claim is covered under Section 14.1 or is caused by the negligence or
willful misconduct of a Sonic Indemnitee.

          14.3  Indemnification Procedures.  A party (the "Indemnitee") that
                --------------------------
intends to claim indemnification under this Article 14 shall promptly notify the
other party (the "Indemnitor") in writing of any claim in respect of which the
Indemnitee or any of its directors, officers, employees,

                                     -11-
<PAGE>

agents, successors, or assigns intends to claim such indemnification, and the
Indemnitor shall have sole control of the defense and/or settlement thereof,
provided that the indemnified party may participate in any such proceeding with
counsel of its choice at its own expense. The indemnity agreement in this
Article 14 shall not apply to amounts paid in settlement of any Claim if such
settlement is effected without the consent of the Indemnitor, which consent
shall not be withheld unreasonably. The failure to deliver written notice to the
Indemnitor within a reasonable time after the commencement of any such action,
if prejudicial to its ability to defend such action, shall relieve such
Indemnitor of any liability to the Indemnitee under this Article 14, but the
omission to so deliver written notice to the Indemnitor shall not relieve the
Indemnitor of any liability that it may otherwise have to any Indemnitee than
under this Article 14. The Indemnitee under this Article 14, its employees and
agents, shall cooperate fully with the Indemnitor and its legal representatives
and provide full information in the investigation of any Claim covered by this
indemnification. Notwithstanding anything to the contrary contained in this
Article 14, neither party shall be liable for any costs or expenses incurred
without its prior written authorization.

15.  MISCELLANEOUS PROVISIONS.
     ------------------------

     15.1  Independent Contractors.  The relationship of Sonic and Starkey
           -----------------------
established by this Agreement is that of independent contractors, and nothing
contained in this Agreement shall be construed to (i) give either party the
power to direct or control the day-to-day activities of the other, (ii)
constitute the parties as partners, joint venturers, co-owners or otherwise as
participants in a joint or common undertaking, or (iii) allow a party to create
or assume any obligation on behalf of the other party for any purpose
whatsoever.

     15.2  Governing Law.  This Agreement and all acts and transactions
           -------------
pursuant hereto and the rights and obligations of the parties hereto shall be
governed, construed and interpreted in accordance with the laws of the State of
Utah, without reference to rules of conflicts or choice of laws.  This Agreement
shall not be governed by the 1980 United Nations Convention on Contracts for the
International Sale of Goods.

     15.3  Arbitration.  If a dispute arises between the parties relating to the
           -----------
interpretation or performances of this Agreement or the grounds for the
termination thereof, representatives of the parties with decision-making
authority shall meet to attempt in good faith to negotiate a resolution of the
dispute prior to pursuing other available remedies. If within thirty (30) days
after such meeting the parties have not succeeded in negotiating a resolution of
the dispute, such dispute shall be submitted to final and binding arbitration
under the then current Commercial Arbitration Rules of the American Arbitration
Association ("AAA") by one (1) arbitrator in Salt Lake City, Utah. Such
arbitrator shall be selected by the mutual agreement of the parties or, failing
such agreement, shall be selected according to the aforesaid AAA rules. The
arbitrator will be instructed to prepare and deliver a written, reasoned opinion
stating his decision within thirty (30) days of the completion of the
arbitration. Such arbitration shall be concluded within nine (9) months
following the filing of the initial request for arbitration. The parties shall
bear the costs of arbitration equally and shall bear

                                     -12-
<PAGE>

their own expenses, including professional fees. The decision of the arbitrator
shall be final and non-appealable and may be enforced in any court of competent
jurisdiction.

          15.4  Notices.  Any notice required or permitted by this Agreement
                -------
shall be in writing and shall be sent by prepaid registered or certified mail,
return receipt requested, internationally recognized courier or personal
delivery, or by fax with confirming letter mailed or otherwise delivered under
the conditions described above in each case addressed to the other party at the
address shown below or at such other address for which such party give notice
hereunder.  Such notice shall be deemed to have been given when delivered:

          If to Starkey:  Starkey Laboratories, Inc.
                          6600 Washington Ave., South
                          Eden Prairie, Minnesota 55344
                          Attn: Jerome Ruzicka
                          Tel.: (612) 941-6401
                          Fax: (612) 828-9262

          If to Sonic:    Sonic Innovations, Inc.
                          5330 S 900 East, Ste. 240
                          Salt Lake City, Utah 84117
                          Attn.: Jorgen Heide
                          Tel.: (801) 288-0993
                          Fax: (801) 288-0998

          15.5  Force Majeure.  Nonperformance of any party hereto (except for
                -------------
payment obligations) shall be excused to the extent that performance is rendered
impossible by strike, fire, earthquake, flood, governmental acts or orders or
restrictions, delay or failure of suppliers, or any other reason where failure
to perform is beyond the reasonable control and not caused by the gross
negligence or willful misconduct of the nonperforming party.

          15.6  Assignment.  This Agreement shall not be assignable by either
                ----------
party to any third party hereto without the written consent of the other party
hereto, except that either party may assign this Agreement without the other
party's consent to an entity that acquires all or substantially all of the
business or assets of the assigning party pertaining to the subject matter
hereof, in each case whether by merger, acquisition, or otherwise.  Any assignee
shall agree to perform the obligations of the assignor of this Agreement, and
this Agreement shall be binding on and inure to the benefit of any permitted
assignee.

          15.7  Partial Invalidity.  If any provision of this Agreement is held
                ------------------
to be invalid by a court of competent jurisdiction, then the remaining
provisions shall remain, nevertheless, in full force and effect.  The parties
agree to renegotiate in good faith any term held invalid and to be bound by the
mutually agreed substitute provision in order to give the most approximate
effect originally intended by the parties.

                                     -13-
<PAGE>

          15.8   Publicity.  The parties may agree upon a press release to
                 ---------
announce the execution of this Agreement, together with a corresponding question
and answer outline for use in responding to inquiries about the Agreement;
thereafter, Sonic and Starkey may each disclose to third parties the information
contained in such press release and question and answer outline without the need
for further approval by the other.  From time to time during the term of this
Agreement, the Parties may agree upon additional press releases.
Notwithstanding the foregoing, neither party may issue any press release or
other publicity or use the name of the other party without both parties' express
written consent.

          15.9   Export Laws.  Notwithstanding anything to the contrary
                 -----------
contained herein, all obligations of Sonic and Starkey are subject to prior
compliance with United States and foreign export regulations and such other
United States and foreign laws and regulations as may be applicable, and to
obtaining all necessary approvals required by the applicable agencies of the
government of the United States and the governments in the Territory. Sonic and
Starkey shall cooperate with each other and shall provide assistance to the
other as reasonably necessary to obtain any required approvals.

          15.10  No Waiver.  No waiver of any term or condition of this
                 ---------
Agreement shall be valid or binding on either party unless agreed in writing by
the party to be charged.  The failure of either party to enforce at any time any
of the provisions of the Agreement, or the failure to require at any time
performance by the other party of any of the provisions of this Agreement, shall
in no way be construed to be a present or future waiver of such provisions, nor
in any way affect the validity of either party to enforce each and every such
provision thereafter.

          15.11  Counterparts.  This Agreement may be executed in two or more
                 ------------
counterparts, each of which shall be deemed an original and all of which
together shall constitute one instrument.

          15.12  Entire Agreement.  This Agreement, including the Exhibits
                 ----------------
attached hereto, constitutes the entire agreement of the parties with respect to
the subject matter hereof, and supersedes all prior or contemporaneous
understandings or agreements, whether written or oral, between Sonic and Starkey
with respect to such subject matter.  The terms of any purchase order are
expressly excluded.  No amendment or modification hereof shall be valid or
binding upon the parties unless made in writing and signed by the duly
authorized representatives of both parties.

                                     -14-
<PAGE>

          IN WITNESS WHEREOF, the undersigned are duly authorized to execute
this Agreement on behalf of Sonic and Starkey as applicable.

SONIC INNOVATIONS, INC.                        STARKEY LABORATORIES, INC.

("Sonic")                                      ("Starkey")

By:  /s/ Jorgen Heide                          By:  /s/ Jerome C. Ruzicka
     --------------------------------------         --------------------------

Print Name:  Jorgen Heide                      Print Name:  Jerome C. Ruzicka
             ------------------------------                -------------------

Title:  Vice President Business Development    Title:  President
        -----------------------------------            -----------------------

                                     -15-
<PAGE>

                                   EXHIBIT A
                                   ---------

                                 SPECIFICATION

                                      [*]
<PAGE>

                                   EXHIBIT B
                                   ---------

                                 Patent Numbers

                       United States Patent No. 5,500,902

                       United States Patent No. 5,848,171
<PAGE>

                                   EXHIBIT C

                           RELIABILITY SPECIFICATION
<PAGE>

TITLE: Solder Stress testing                               SPEC.NO.99012-006

                                    Purpose
1.0  Purpose
-----------

     This document describes the test methods for performing soldering stress
simulation on hearing aid amplifiers.  This test simulates thermal shock effects
subjected to amplifiers during hearing aid production.  Thermal shock effects
can cause delamination of encapsulation epoxy on thickfilm hybrids, cause
blistering or delamination in FR4 epoxy boards, or cause failure due to poor
electrical connections.  This testing determines if the amplifier under test is
prone to the above types of failures or any other type of failure.

2.0  Equipment/Materials
------------------------

          Soldering iron
          Solder pot
          Flux
          Tweezers
          Microscope with range of 30X-200X
          Amplifier print (for reference)

3.0  Procedure
--------------

     Check that all test circuits have been electrically tested and an
electrical response representing each is available for later review.  Mark the
test circuits so they may be easily identified after solder stress testing and
submitted for electrical re-test.

     Method 1 (Glencoe wiring simulation)
     ------------------------------------

     Hybrid amplifier circuits: Inspect closely under 200X magnification for any
     evidence of delamination.

     Surface Mount amplifiers: Inspect closely at 30X for any evidence of kapton
     separation or FR4 damage.

     Do not perform Glencoe wiring simulation on any test sample that exhibits
     any evidence of delamination or damage.  Report results to QE before
     continuing test.

     Set-up
     ------

     .    Install new tip into soldering iron.
     .    Set soldering iron tip to approximately 700F.
     .    Apply flux (as needed) to amplifier circuit.
<PAGE>

TITLE: Solder Stress testing                             SPEC.NO.99012-006

     Glencoe Solder Stress test:
     --------------------------

     .    Apply soldering iron to solder pad #1 on test circuit #1 and dwell for
     about three seconds. Remove iron for about three seconds. Repeat
     solder/desolder cycle twice more for a total of three cycles.

     .    Apply soldering iron to solder pad #1 on test circuit #2 and dwell for
     about three seconds. Remove iron for about three seconds. Repeat
     solder/desolder cycle twice more for a total of three cycles.

     .    Return to test circuit #1 and apply soldering iron to solder pad #2
     and apply three cycles of solder/desolder, as described in the previous
     step. Repeat procedure on test circuit #2 with pad #2.

     .    Repeat three cycles of solder/desolder as described in the steps above
     for every pad on all test circuits.

     Note:  Any sequence of applying three cycles of solder/desolder is
     acceptable as long as the circuit under test does not encounter consecutive
                                                                     -----------
     applications of solder/desolder cycling to different pads on the same
     circuit.  Using circuit pairs for the test, as described in this procedure,
     is the simplest and most time effective method.

     Post-test visual inspection:
     ---------------------------

     Hybrid circuits:  Inspect closely at 200X for any evidence of delamination.

     Surface Mount circuits:  Inspect closely at 30X for any evidence of damage.

     Electrical re-test
     ------------------

     Submit all samples to hybrid lab for electrical retest.  Compare post-test
     response with pre-test response for each test circuit.  Note any
     significant shift in response.

     Method 2 (Solder pot method)
     ----------------------------

     Note:  This method applies only to hybrid thickfilm circuit amplifiers.

     Inspect closely under 200X magnification for any evidence of delamination.
     Do not perform Glencoe wiring simulation on any test sample that exhibits
     any evidence of delamination or damage.  Report result to QE before
     continuing test.

     .    If not otherwise directed by QE, set solder pot temperature to
     approximately 238C.

     .    Use tweezers and dip hybrid into solder pot for a duration of three
     seconds. Allow to cool for about thirty seconds, and repeat solder pot
     dips.

     .    After three dips, look closely for delamination at 200X magnification.
     Observe for any evidence of delamination. Three dips is the minimum
     exposure required for method 2 of Solder Stress Testing.
<PAGE>

TITLE: Solder Stress testing                               SPEC.NO.99012-006

     .    If required, remove any solder bridges with soldering iron.

     Electrical re-test
     ------------------

     Submit all samples to hybrid lab for electrical test.  Compare post-test
     response with pre-test response for each test circuit.  Note any
     significant shift in response.

4.0  Reference Documents
------------------------

     None

5.0  Records
------------

     Test Information compiled in reliability lab evaluation report.
<PAGE>

                Amendment to OEM Agreement Dated April 19, 1999
                                    Between
                     SONIC Innovations, Inc. ("SONIC") and
                    Starkey Laboratories, Inc. ("Starkey")

     SONIC and Starkey agree to amend their OEM Agreement as follows:

     DATE OF AMENDMENT
     ------------------
     December 14, 1999

          19.1 GENERAL

     Starkey agrees to provide SONIC a two-year, guaranteed, non-cancelable
     blanket purchase order for the purchase of SONIC Hybrids.

     TERM
     ----
     January 1, 2000 through December 31, 2001.

     QUANTITY
     --------
     Starkey agrees to purchase a minimum of [ * ] Hybrids per calendar year in
     each of 2000 and 2001.

     CURRENT GENERATION HYBRID PRICING
     ---------------------------------

     For the current generation Hybrid, part number 2000444, the pricing for the
     first [ * ] Hybrids ordered shall be $[ * ] each.

     For quantities above [ * ] Hybrids, pricing shall be $[ * ] each.

          21.2 NEW GENERATION HYBRID PRICING
     For new generation Hybrids, the pricing for the first Hybrids shall be
     $185.00 each.

     For Hybrid quantities [ * ]  through [ * ], pricing shall be $[ * ]  each.

     For Hybrid quantities [ * ]  through [ * ], pricing shall be $[ * ]  each.

     For Hybrid quantities [ * ]  through [ * ], pricing shall be $[ * ]  each.

     For Hybrid quantities greater than [  * ], pricing shall be negotiated.

/s/ Jorgen Heide                           /s/ Jerome C. Ruzicka
---------------------------                ---------------------
Jorgen Heide                               Jerome C. Ruzicka
VP International & Licensing Division      President, Starkey Laboratories, Inc.
SONIC Innovations, Inc.

[ * ]= CERTAIN INFORMATION ON THIS PAGE HAS BEEN OMITTED AND FILED SEPARATELY
WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO
THE OMITTED PORTIONS.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00002-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00002-of-00352.parquet"}]]